Priority 13 from the Blood Transfusion and Blood Donation PSP

UNCERTAINTY: Which patients groups would benefit most from artificial blood* products? *Artificial blood is a product made to act as a substitute for red blood cells with the sole purpose of transporting oxygen and carbon dioxide throughout the body. (JLA PSP Priority 13)
Overall ranking	13
JLA question ID	0063/13
Explanatory note	Not available for this PSP
Evidence	No systematic review evidence available
Health Research Classification System category	Generic Health Relevance

Extra information provided by this PSP
Original uncertainty examples	Where is the development of artificial blood and blood products? ~ Are there substances that can be used to avoid blood transfusion? ~ What is the progress on the current research into manufactured red cells? ~ Are there any synthetic alternatives so that one does not have to donate? ~ Can we use synthetic agents to carry oxygen in the blood until the body is able to manufacture its own red cells and therefore avoid the need for inter-human transfusion?
Submitted by	2 blood recipients ~ 6 relative or carers of blood recipients ~ 10 blood donors ~ 15 health professionals ~ 7 unknown ~ 1 Jehovah's Witness

Extra information provided by this PSP

Original uncertainty examples

Where is the development of artificial blood and blood products? ~ Are there substances that can be used to avoid blood transfusion? ~ What is the progress on the current research into manufactured red cells? ~ Are there any synthetic alternatives so that one does not have to donate? ~ Can we use synthetic agents to carry oxygen in the blood until the body is able to manufacture its own red cells and therefore avoid the need for inter-human transfusion?

Submitted by

2 blood recipients ~ 6 relative or carers of blood recipients ~ 10 blood donors ~ 15 health professionals ~ 7 unknown ~ 1 Jehovah's Witness

PSP information
PSP unique ID	0063
PSP name	Blood Transfusion and Blood Donation
Total number of uncertainties identified by this PSP	51 (To see a full list of all uncertainties identified, please see the detailed spreadsheet held on the JLA website)
Date of priority setting workshop	28 February 2018